The short version
- What it doesRutin is quercetin wearing a disaccharide, and the disaccharide is the whole page. Formally quercetin-3-O-rutinoside: the aglycone carries rutinose, rhamnose linked alpha-1,6 to glucose, at the 3-position.
- Who it is forPeople with heavy, aching legs, visible small vessels or mild venous insufficiency who want the flavonoid route. Not a substitute for compression.
- What to watchWell tolerated. Headache, flushing and GI upset at higher doses.
How Rutin works
Rutin is quercetin-3-O-rutinoside: the aglycone quercetin carrying rutinose, a disaccharide of rhamnose and glucose. Human small intestine has lactase-phlorizin hydrolase and cytosolic beta-glucosidase, both of which handle quercetin monoglucosides efficiently; neither cleaves the alpha-1,6 rhamnosidic bond in rutinose.
Read the rest of how it works
So rutin passes the small intestine largely intact and is deglycosylated by colonic bacteria — chiefly rhamnosidase-producing organisms — before the freed quercetin is absorbed, conjugated in the enterocyte and liver, and circulated as glucuronides and sulfates. That single step puts peak plasma exposure hours later than a quercetin glucoside, makes the size of the exposure depend on the microbiome, and explains why the venous pharmacology was developed on hydroxyethylrutosides instead, a semisynthetic derivative built to be absorbed without waiting for bacteria.
Rutin: serving, timing and spacing
- Suggested serving
- Capsules are 250–500 mg, once or twice daily. The venous literature is on hydroxyethylrutosides at roughly 1 g per day, which is a different molecule at a different dose.
- How often
- Twice daily
- When
- With or without food - the rate-limiting step is colonic bacterial removal of the rutinose rather than gastric emptying, so meal timing changes very little. What does change it is a recent course of antibiotics
- Spacing that matters for safety
- Stop it at least two weeks before surgery on the antiplatelet grounds, and space it from any narrow-therapeutic-index drug, because what gets absorbed is quercetin and quercetin inhibits several CYP enzymes
General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.
Good to know
Plain rutin and Venoruton are not the same product. If the reason for buying it is the venous trial data, the trials were done on the hydroxyethylated derivative — read the label and see which one is in the bottle.
Research on Rutin5 evidence notes: clinical, correlative, theoretical
Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work
Human clinical evidence
The venous trials in this family were run on hydroxyethylrutosides, a semisynthetic derivative, not on plain rutin: a prospective controlled study of O-(beta-hydroxyethyl)-rutosides reported rapid relief of signs and symptoms in chronic venous insufficiency and microangiopathy.
An eight-month open registry of the same derivative reported sustained symptom improvement and analyzed it on cost-efficacy grounds.
A 2025 systematic review and meta-analysis of pharmacological interventions for chronic venous insufficiency places the flavonoid fractions among the interventions with usable efficacy and safety data.
Correlative data
Dietary intake of quercetin glycosides — rutin is the most abundant one in buckwheat, capers and citrus peel — associates with lower cardiovascular risk in cohort data, where the exposure is a whole-food pattern and not a capsule.
Theoretical / extrapolated benefits
The capillary-sealing claim is attributed to reduced endothelial permeability and to inhibition of the enzymes that degrade the vessel wall matrix. The chemistry is coherent; the specific step from an oral rutin capsule to a measured change in a human capillary bed is where the evidence thins.
Sources read for this page
- Cesarone MR. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology 2005 · PMID 15793606
- Cesarone MR. Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton (HR): an 8-month, open-registry, cost-efficacy study. Panminerva Med 2010 · PMID 20657534
- Miguel CB. Emerging Pharmacological Interventions for Chronic Venous Insufficiency: A Comprehensive Systematic Review and Meta-Analysis of Efficacy, Safety, and Therapeutic Advances. Pharmaceutics 2025 · PMID 39861707
- Li KX, et al. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review.. Research and Practice in Thrombosis and Haemostasis 2021 · PMID 34027293
- Sobreiro MA. Enzymatic Hydrolysis of Rutin: Evaluation of Kinetic Parameters and Anti-Proliferative, Mutagenic and Anti-Mutagenic Effects. Life (Basel) 2023 · PMID 36836907
- Al-Ishaq RK. Enzymatic Metabolism of Flavonoids by Gut Microbiota and Its Impact on Gastrointestinal Cancer. Cancers (Basel) 2021 · PMID 34439088
Rutin, the deep readThe mechanism, cell to human, which form, how you would know
What Rutin actually does
Rutin is quercetin wearing a disaccharide, and the disaccharide is the whole page. Formally quercetin-3-O-rutinoside: the aglycone carries rutinose, rhamnose linked alpha-1,6 to glucose, at the 3-position. That sugar makes it far more water-soluble than quercetin and far less absorbable, for a reason that is enzymatic rather than physical.
The human small intestine has two routes for flavonoid glycosides and rutinose fits neither. Lactase-phlorizin hydrolase at the brush border and cytosolic beta-glucosidase after SGLT1 uptake both handle quercetin-4'-glucoside and quercetin-3-glucoside efficiently. Neither cleaves an alpha-1,6 rhamnosidic bond. So rutin traverses the small intestine substantially intact and meets its first competent enzyme in the colon, where bacterial alpha-rhamnosidases and beta-glucosidases remove the sugars Al-Ishaq 2021. The freed quercetin is then absorbed, conjugated in the enterocyte and liver by UGT and SULT enzymes, and circulates almost entirely as glucuronides and sulfates rather than as free aglycone.
Three consequences follow, and all three are practical. Peak plasma exposure after rutin arrives hours later than after a quercetin glucoside. The size of that exposure depends on which organisms are present, which means it varies between people and can change after a course of antibiotics. And because the colon is the site of conversion, a large part of the dose is metabolized further by the microbiota into small phenolic acids that are not quercetin at all.
Enzymatic hydrolysis of rutin has been characterized in the laboratory precisely because of this — kinetic parameters have been measured, and the hydrolysis products differ from the parent in their biological effects Sobreiro 2023. That work is the clearest statement that rutin and quercetin are not interchangeable names for one thing.
The vascular mechanism, where it has been studied, is about the capillary wall rather than the blood. Reduced endothelial permeability, inhibition of the enzymes that degrade the glycocalyx and the subendothelial matrix, and reduced leukocyte adhesion are the proposed steps behind the edema and heaviness endpoints the venous literature measures Li 2021.
Cell, rodent, human — and where it stops
The translation problem on this page is not species. It is that the trials were run on a different molecule.
In people, the venous data belongs to hydroxyethylrutosides. A prospective controlled study of O-(beta-hydroxyethyl)-rutosides reported rapid relief of the signs and symptoms of chronic venous insufficiency and microangiopathy Cesarone 2005, and an eight-month open registry of the same preparation reported sustained improvement and analyzed it on cost-efficacy grounds Cesarone 2010. Those are the studies people have in mind when they buy rutin.
Hydroxyethylrutosides are semisynthetic. Rutin is hydroxyethylated to a defined mixture — mono-, di-, tri- and tetrahydroxyethyl derivatives — specifically to produce a molecule that is absorbed without waiting for colonic bacteria to remove rutinose. The daily dose in that literature is around 1 g. A 500 mg plain rutin capsule is neither the molecule nor the dose.
In the wider evidence base, the flavonoid class does hold up. A 2025 systematic review and meta-analysis of pharmacological interventions for chronic venous insufficiency places the flavonoid fractions among the interventions with usable efficacy and safety data Miguel 2025, and micronized purified flavonoid fraction — again a specifically engineered preparation, not a raw flavonoid — carries its own narrative evidence base Li 2021. The pattern across the whole category is that the products with trial data are the ones somebody modified for absorption.
So the honest chain is: mechanism in the vessel wall, trials on derivatives, and a capsule of the unmodified parent whose systemic exposure depends on a colonic conversion nobody measured in any of those trials.
Rutin — which form, and does it matter
Four things are sold under this heading and they are not equivalent. Plain rutin (quercetin-3-O-rutinoside), isoquercitrin or enzymatically modified isoquercitrin (the 3-O-glucoside, which the small intestine can cleave), troxerutin and the hydroxyethylrutoside mixtures, and quercetin aglycone itself. Absorption rises across that list roughly in the order given, and the price does not track it.
The single most useful comparison is rutin against its own glucoside. Removing rhamnose from rutin to leave quercetin-3-glucoside converts a compound the small intestine cannot handle into one it handles well, because lactase-phlorizin hydrolase and cytosolic beta-glucosidase both act on glucosides. That is one sugar residue changing the site of absorption from colon to duodenum, and with it the time to peak from many hours to about one Al-Ishaq 2021 Sobreiro 2023.
Exposure arithmetic, stated plainly. Capsules are 250 to 500 mg once or twice daily. The venous trials ran hydroxyethylrutosides at roughly 1,000 mg per day Cesarone 2005 Cesarone 2010. Even if plain rutin were fully converted — it is not — 500 mg of rutin contains about 270 mg of quercetin by mass, because rutinose is roughly 45 percent of the molecular weight. Half the label is sugar.
The microbiome is a formulation variable here in a way it is for almost nothing else on this shelf. Two people can take the same capsule and generate different systemic exposure because they carry different rhamnosidase-producing organisms, and a recent antibiotic course can genuinely change how much of a dose ever becomes active.
What would have to be true, and how you would know it was not
If plain rutin is producing systemic quercetin, urinary and plasma quercetin conjugates rise with a delayed peak. The falsifiable version: sampled against a matched dose of quercetin-3-glucoside, rutin should peak several hours later and lower. If a study found the two curves superimposable, the entire colonic-conversion account on this page would be wrong.
For a reader, the read-out is the leg and it has to be measured rather than remembered. Ankle circumference taken at the same point each evening, and a symptom score for heaviness and aching, logged for two weeks before starting. The venous trials measured exactly these Cesarone 2005. Judge at eight weeks.
The prediction that cuts against the product. If the reason for taking it is the Venoruton data, plain rutin at 500 mg should underperform hydroxyethylrutosides at 1,000 mg, because it is a smaller dose of a less absorbable form. Anyone who finds them equivalent has falsified the form argument this page makes, and that result would be worth publishing.
hs-CRP is the wrong marker here and is named only to say so: the venous claim is mechanical and microvascular, not systemically inflammatory, and a normal CRP neither supports nor refutes it.
What nobody has tested yet
Nobody has stratified a rutin trial by microbiome. The conversion is bacterial Al-Ishaq 2021, the conversion capacity varies between people, and no clinical study of rutin has grouped participants by whether they can perform it. That is the single most obvious experiment this molecule is missing, and it would explain a great deal of the inconsistency in the literature.
Plain rutin has never been compared head to head with hydroxyethylrutosides in the same trial. The comparison is easy, the outcome measures are established Miguel 2025, and the result would tell every purchaser of a rutin capsule whether they bought the right thing.
And the antibiotic question is entirely untested. If systemic exposure depends on colonic rhamnosidase activity, then a course of broad-spectrum antibiotics should measurably reduce it. Nobody has looked, and it is the kind of interaction that would never show up in a conventional drug-interaction screen because there is no enzyme in the human genome involved.
Rutin — its own safety story, not its category's
Rutin's own safety story is short, and the interesting part is that its risks belong to its metabolite rather than to itself.
Whatever is absorbed becomes quercetin, and quercetin inhibits several cytochrome P450 enzymes and drug transporters. That is the interaction to take seriously with narrow-therapeutic-index drugs, and it is not predictable from the parent molecule's own inertness Sobreiro 2023.
Mild antiplatelet activity runs through the flavonoid class and is additive with anticoagulants, antiplatelets and aspirin. As with every pharmacodynamic interaction it does not show up as a changed drug level — it shows up as bruising or a longer bleeding time.
Headache, flushing and gastrointestinal upset are the common complaints at 1 g and above, and are the reason most people settle at a lower dose than the trials used.
The genuinely unusual one: a recent antibiotic course can change this supplement's activity. Because activation is bacterial rather than hepatic, the same capsule can do less after a course of antibiotics than it did before Al-Ishaq 2021. That is worth knowing and is not an interaction any pharmacy database will flag.
Safety in pregnancy and breastfeeding at supplemental doses is not established, and the venous complaint most likely to prompt somebody to take it — heavy, aching legs — is common in pregnancy. Compression is the intervention with evidence in that setting.
Rutin safety basics4 points of its own
Its own safety story
- Well tolerated. Headache, flushing and GI upset at higher doses.
- Flavonoids of this class have mild antiplatelet activity and rutin is metabolized to quercetin, which inhibits several CYP enzymes. Both matter with anticoagulants and with narrow-therapeutic-index drugs.
- Because absorption depends on colonic bacteria, a course of antibiotics can genuinely change how much of a dose ever becomes active. That is unusual and it is worth knowing.
- Safety in pregnancy and breastfeeding is not established at supplemental doses.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.
Bloodwork to run4 tests in one order, code CAMERON
The effect itself has no blood test. That is a fact about the effect, and it changes how you should judge it.
- What to watchAnkle circumference measured at the same landmark each evening, and a written score for heaviness and aching. Those are the endpoints the hydroxyethylrutoside trials used, and both need two weeks of baseline before the first capsule or there is nothing to compare against.
- How long before it means anythingEight weeks. Systemic exposure to the active depends on colonic bacteria removing the rutinose, which puts the effect hours downstream of every dose and makes a two-day impression worthless.
- What will fool youThe weather and the day. Leg swelling tracks heat, standing hours and salt intake far more strongly than any flavonoid does, so a supplement started in September will look effective by November. Compression stockings, if they were started in the same week, are the intervention with the stronger evidence and will take the credit.
The labs mapped to Rutin
Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.
Rutin FAQ5 common questions
- What is Rutin?
- Quercetin with a disaccharide bolted onto its 3-position. That sugar is the whole story: it makes rutin far more water-soluble than quercetin and far less absorbable, because the small intestine has no enzyme that cleaves rutinose. Anything rutin does systemically, it does after colonic bacteria take the sugar off — which puts the effect hours downstream and makes it depend on whose gut it lands in.
- What is the suggested dose of Rutin?
- Capsules are 250–500 mg, once or twice daily. The venous literature is on hydroxyethylrutosides at roughly 1 g per day, which is a different molecule at a different dose. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
- Who is Rutin for?
- People with heavy, aching legs, visible small vessels or mild venous insufficiency who want the flavonoid route. Not a substitute for compression.
- Which labs show whether Rutin is doing anything?
- ApoB (Apolipoprotein B), Lipoprotein(a) — Lp(a), hs-CRP (High-Sensitivity C-Reactive Protein), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides). Draw a baseline before you start, then recheck.
- Where can I buy Rutin?
- Coach Cam sources Rutin from vetted, top-rated brands on iHerb. Use the buy link on this page.



